Brookdale Senior Living upgraded to Top Pick from Outperform at RBC Capital RBC Capital upgraded Brookdale Senior Living to Top Pick due to attractive fundamentals and its leading industry positing in private long-term capital. Price target raised to $42 from $38.
Brookdale Senior Living downgraded to Neutral from Buy at BofA/Merrill BofA/Merrill downgraded Brookdale Senior Living to Neutral and lowered its price target to $25 from $35. The firm sees limited upside potential over the next year given weak industry fundamentals and ongoing issues around the Emeritus integration. BofA/Merrill said Q3 industry data indicates it will be difficult for Brookdale to show near-term improvement.